Steroid-sparing effects of fluticasone propionate 100 μg and salmeterol 50 μg administered twice daily in a single product in patients previously controlled with fluticasone propionate 250 μg administered twice daily
- 31 January 2003
- journal article
- clinical trial
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 111 (1), 57-65
- https://doi.org/10.1067/mai.2003.38
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Impact of Inhaled Antiinflammatory Therapy on Hospitalization and Emergency Department Visits for Children With AsthmaPediatrics, 2001
- Low-Dose Inhaled Corticosteroids and the Prevention of Death from AsthmaNew England Journal of Medicine, 2000
- Meta-analysis of increased dose of inhaled steroid or addition of salmeterol in symptomatic asthma (MIASMA)BMJ, 2000
- AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 2000
- Efficacy and Safety of Inhaled CorticosteroidsAmerican Journal of Respiratory and Critical Care Medicine, 1998
- Effect of Inhaled Formoterol and Budesonide on Exacerbations of AsthmaNew England Journal of Medicine, 1997
- Effect of short-term treatment with low-dose inhaled fluticasone propionate on airway inflammation and remodeling in mild asthma: a placebo-controlled study.American Journal of Respiratory and Critical Care Medicine, 1997
- Effect of long term treatment with salmeterol on asthma control: a double blind, randomised crossover studyBMJ, 1997
- Effect of Early vs Late Intervention With Inhaled Corticosteroids in AsthmaChest, 1995
- Effects of Reducing or Discontinuing Inhaled Budesonide in Patients with Mild AsthmaNew England Journal of Medicine, 1994